232 related articles for article (PubMed ID: 2833185)
1. Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy.
Doherty M; Richards N; Hornby J; Powell R
Ann Rheum Dis; 1988 Mar; 47(3):190-7. PubMed ID: 2833185
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the complement split product C3dg in synovial fluid as a possible diagnostic guide in inflammatory arthropathies.
Michel BA; Schlumpf U; Simmler F
J Rheumatol; 1989 Sep; 16(9):1201-4. PubMed ID: 2810276
[TBL] [Abstract][Full Text] [Related]
3. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex.
Mollnes TE; Lea T; Mellbye OJ; Pahle J; Grand O; Harboe M
Arthritis Rheum; 1986 Jun; 29(6):715-21. PubMed ID: 3718564
[TBL] [Abstract][Full Text] [Related]
4. Synovial fluid calcium pyrophosphate dihydrate crystals and alizarin red positivity: analysis of 3000 samples.
Hamilton E; Pattrick M; Hornby J; Derrick G; Doherty M
Br J Rheumatol; 1990 Apr; 29(2):101-4. PubMed ID: 2157516
[TBL] [Abstract][Full Text] [Related]
5. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
6. Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.
Pattrick M; Hamilton E; Hornby J; Doherty M
Ann Rheum Dis; 1991 Apr; 50(4):214-8. PubMed ID: 1851409
[TBL] [Abstract][Full Text] [Related]
7. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of immunoglobulins and complement factors in synovial fluid and serum in rheumatoid arthritis, seronegative spondyloarthropathies and osteoarthritis: pathophysiology and retrospective analysis of clinical value].
Möller B; Kessler U; Braner A; Dielehner N; Kaltwasser JP
Z Rheumatol; 2002 Feb; 61(1):48-57. PubMed ID: 11974492
[TBL] [Abstract][Full Text] [Related]
9. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis.
Mollnes TE; Paus A
Arthritis Rheum; 1986 Nov; 29(11):1359-64. PubMed ID: 3778542
[TBL] [Abstract][Full Text] [Related]
10. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
Brodeur JP; Ruddy S; Schwartz LB; Moxley G
Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
[TBL] [Abstract][Full Text] [Related]
11. Complement C3 cleavage product in synovial fluids detected by immunofixation.
Partsch G; Bauer K; Bröll H; Petera P; Dunky A; Merétey K
Z Rheumatol; 1991; 50(2):82-5. PubMed ID: 1872046
[TBL] [Abstract][Full Text] [Related]
12. Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid.
Høgåsen K; Mollnes TE; Harboe M; Götze O; Hammer HB; Oppermann M
J Rheumatol; 1995 Jan; 22(1):24-8. PubMed ID: 7535360
[TBL] [Abstract][Full Text] [Related]
13. Synovial fluid macrophages are capable of osteoclast formation and resorption.
Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
[TBL] [Abstract][Full Text] [Related]
14. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis.
Olmez U; Garred P; Mollnes TE; Harboe M; Berntzen HB; Munthe E
Scand J Rheumatol; 1991; 20(3):183-9. PubMed ID: 2068540
[TBL] [Abstract][Full Text] [Related]
15. Does acute synovitis (pseudogout) occur in patients with chronic pyrophosphate arthropathy (pseudo-osteoarthritis)?
Schlesinger N; Hassett AL; Neustadter L; Schumacher HR
Clin Exp Rheumatol; 2009; 27(6):940-4. PubMed ID: 20149309
[TBL] [Abstract][Full Text] [Related]
16. Citrate in synovial fluid and its relation to inflammation and crystal presence.
Van Linthoudt D; Salani I; Zender R; Locatelli P; Ott H; Schumacher HR
J Rheumatol; 1996 Mar; 23(3):502-5. PubMed ID: 8832992
[TBL] [Abstract][Full Text] [Related]
17. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
18. Inorganic pyrophosphate pool size and turnover rate in arthritic joints.
Camerlain M; McCarty DJ; Silcox DC; Jung A
J Clin Invest; 1975 Jun; 55(6):1373-81. PubMed ID: 166095
[TBL] [Abstract][Full Text] [Related]
19. Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis.
Moxley G; Ruddy S
Arthritis Rheum; 1985 Oct; 28(10):1089-95. PubMed ID: 3876836
[TBL] [Abstract][Full Text] [Related]
20. Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin.
Hasselbacher P
Arthritis Rheum; 1979 Mar; 22(3):243-50. PubMed ID: 105740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
